Lamictal

Lamotrigine, the active ingredient in Lamictal, is an antiepileptic presented as an oral tablet for oral use. It is prescribed to manage seizures in epilepsy and to stabilize mood in bipolar disorder. It is approved for use in the European Union and is available in various dosage strengths.

GNH USA supplies Lamictal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and provides regulatory documentation to support import and distribution.

Lamotrigine is used in the management of seizure disorders and mood stabilization in bipolar disorder.

- Epilepsy: Reduces frequency and severity of focal and generalized seizures. - Bipolar disorder: Helps prevent mood episodes and maintains long‑term stability. - Adjunct therapy for refractory seizures: Used alongside other antiepileptics when seizures are not controlled.

Lamotrigine may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness: Transient sensation of light‑headedness. - Headache: Mild to moderate pain often resolving with continued therapy. - Nausea: Gastrointestinal upset that may lessen over time. - Rash: Skin irritation ranging from mild erythema to pruritus. - Blurred vision: Temporary visual disturbances. - Insomnia: Difficulty initiating or maintaining sleep.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: Severe skin reaction requiring immediate discontinuation. - Toxic epidermal necrolysis: Life‑threatening skin detachment. - Blood dyscrasias: Aplastic anemia or agranulocytosis. - Hepatic failure: Marked liver enzyme elevation. - Suicidal thoughts: Emergence of depressive or suicidal ideation. - Severe hypersensitivity: Multi‑system allergic response.

When prescribing lamotrigine, clinicians should consider several safety measures.

- Titration schedule: Follow a gradual dose‑increase protocol to minimise rash risk. - Skin reactions: Monitor for any rash or hypersensitivity and discontinue if severe. - Hepatic impairment: Use with caution in patients with liver dysfunction; adjust dosing as needed. - Pregnancy: Evaluate risk‑benefit carefully; data are limited, and alternative therapy may be preferred. - Drug interactions: Review concomitant medications for potential alterations in lamotrigine levels. - Store at ambient temperature: Keep in the original packaging, protect from moisture and store below 25 °C.

Lamotrigine interacts with several medicines; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - Valproic acid: Increases lamotrigine plasma concentrations, raising toxicity risk. - Carbamazepine: Decreases lamotrigine levels, potentially reducing efficacy. - Oral contraceptives: Accelerate lamotrigine clearance, possibly requiring dose adjustment.

Moderate Interactions (Monitor Closely): - NSAIDs: May heighten the incidence of skin rash. - Serotonergic agents: Potential for serotonin syndrome; monitor for agitation, hyperreflexia, or fever.